Log In
Print
BCIQ
Print
Print this Print this
 

CLS-1001, CLS-TA

Also known as: CLS 1001

  Manage Alerts
Collapse Summary General Information
Company Clearside Biomedical Inc.
DescriptionTriamcinolone acetonide delivered using the company's ocular microinjection platform
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today